Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Krukenberg Tumor 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1

Interventions

Paclitaxel 8 Hyperthermic Intraperitoneal Chemotherapy 6 Mitomycin 5 Cisplatin 5 Fluorouracil 4 Bevacizumab 4 Oxaliplatin 3 Leucovorin 3 Doxorubicin 3 Cytoreduction Surgical Procedures 3 Carboplatin 3 Blood Specimen Collection 3 sodium thiosulfate 2 pembrolizumab 2 Standard of Care 2 Laparoscopy 2 soluble LAG-3 protein, human 1 relacorilant 1 oregovomab 1 olaparib 1 nilotinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 dehydroftorafur 1 avelumab 1 X-Rays 1 Topotecan 1 Taxes 1 Specimen Handling 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Laparotomy × 1 year × Clear all

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡